In the relentless corridors of Wall Street in 2018, investment banker Andrée Fjeldheim found herself drowning in the familiar cycle—guzzling six cups of coffee daily, experiencing midday crashes, followed by more caffeine and eventual sleep disruption. Across the country in San Francisco, Rashad Hossain was fighting the same battle as a tech executive, his body rebelling against the constant caffeine assault. Neither knew that their parallel struggles would converge into The RYZE Mushroom Coffee—a company that would transform the $20 billion specialty coffee market and create an entirely new category along the way.